Flanagan EP, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Clinical features and diagnosis. https://www.uptodate.com/contents/search. Accessed Sept. 11, 2023.
Flanagan EP, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Treatment and prognosis. https://www.uptodate.com/contents/search. Accessed Sept. 11, 2023.
Banwell B, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. The Lancet Neurology. 2023; doi:10.1016/S1474-4422(22)00431-8.
Flanagan EP, et al. Comparison of inflammatory demyelinating diseases of the central nervous system. https://www.uptodate.com/contents/search. Accessed Sept. 11, 2023.
Sechi E, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A review of clinical and MRI features, diagnosis, and management. The Frontiers in Neurology. 2022; doi:10.3389/fneur.
2022.885218
.
Chen JJ, et al. Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin oligodendrocyte glycoprotein antibody-associated disease. JAMA Neurology. 2022; doi:10.1001/jamaneurol.2022.0489.
Sechi E, et al. Comparison of MRI lesion evolution in different central nervous system demyelinating disorders. Neurology. 2021; doi:10.1212/WNL.0000000000012467.